Variable | Univariable analysis | Multivariable analysis | |||
---|---|---|---|---|---|
Hazard Ratio (95% CI) | P | Hazard Ratio (95% CI) | P | ||
Age at diagnosis (continuous) | 1.014 (1.013–1.015) | < 0.0001 | 1.012 (1.011–1.013) | < 0.0001 | |
Sex | Male | Reference | Â | Reference | Â |
Female | 0.937 (0.919–0.955) | < 0.0001 | 0.925 (0.907–0.943) | < 0.0001 | |
Race | White | Reference | Â | Reference | Â |
Black | 1.020 (0.988–1.054) | < 0.226 | 1.029 (0.994–1.064) | < 0.102 | |
non-white non-black | 0.819 (0.774–0.867) | < 0.0001 | 0.856 (0.807–0.908) | < 0.0001 | |
Education | > = 13% HG | 1.119 (1.097–1.141) | < 0.0001 | 1.071 (1.045–1.096) | < 0.0001 |
< 13% HG | Reference |  | Reference |  | |
Income | > = $35,000 | Reference |  | Reference |  |
<$35,000 | 1.145 (1.123–1.167) | < 0.0001 | 1.091 (1.065–1.117) | < 0.0001 | |
Place of Living | Urban | Reference | Â | Reference | Â |
Rural | 1.140 (1.064–1.222) | < 0.0002 | NS | 0.150 | |
Hospital Type | Academic | Reference | Â | Reference | Â |
Community | 1.199 (1.176–1.222) | < 0.0001 | 1.198 (1.174–1.222) | < 0.0001 | |
Insurance Status | Insured | Reference | Â | Reference | Â |
Not insured | 0.964 (0.903–1.028) | 0.196 | 1.081 (1.011–1.156) | < 0.024 | |
Charlson/Deyo Score | 0 | Reference | Â | Reference | Â |
1 | 1.099 (1.075–1.124) | < 0.0001 | 1.061 (1.038–1.086) | < 0.0001 | |
> = 2 | 1.302 (1.258–1.348) | < 0.0001 | 1.232 (1.189–1.276) | < 0.0001 | |
Year of Diagnosis | 2004–2010 | 1.156 (1.134–1.179) | 0.0001 | 1.155 (1.132–1.179) | 0.0001 |
2011–2016 | Reference |  | Reference |  | |
Chemotherapy | Yes | Reference | Â | Reference | Â |
No | 1.217 (1.192–1.242) | < 0.0001 | 1.137 (1.109–1.165) | < 0.0001 | |
Radiation Therapy | Yes | Reference | Â | Reference | Â |
No | 1.117 (1.095–1.139) | < 0.0001 | 1.032 (1.008–1.057) | < 0.008 | |
Immunotherapy | Yes | 0.773 (0.702–0.850) |  | 0.900 (0.814–0.995) |  |
No | reference | < 0.0001 | reference | < 0.039 |